Literature DB >> 20333644

Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1.

Hira Lal Goel1, Jean M Underwood, Jeffrey A Nickerson, Chung-Cheng Hsieh, Lucia R Languino.   

Abstract

The beta1 integrins play an important role in the modulation of cancer cell proliferation and tumor growth. We have previously shown that beta1 integrins associate with insulin-like growth factor type 1 receptor (IGF-IR) and regulate IGF-stimulated prostate cancer cell proliferation. In the present study, we find that downregulation of beta1 in prostate cancer cells inhibits IGF-IR and AKT activation. We also show that beta1 downregulation in two- and three-dimensional (3D) prostate cancer cell cultures significantly reduces expression of GLI1, a transcription factor known to be regulated by the IGF/AKT signaling pathway and to be a downstream effector of sonic hedgehog. Re-expression of GLI1 rescues the inhibitory effect of beta1 downregulation on prostate cancer cell proliferation in 3D cultures. We find that downregulation of beta1 significantly reduces surface expression of the associated alpha 5 integrin subunit. Our results indicate that the beta1/IGF-IR complex regulates expression of GLI1, which in turn promotes cancer cell proliferation in 3D cultures. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333644      PMCID: PMC2885855          DOI: 10.1002/jcp.22116

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

Review 1.  Integrin adhesion receptors in tumor metastasis.

Authors:  Brunhilde Felding-Habermann
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 2.  Integrin and growth factor receptor crosstalk.

Authors:  B P Eliceiri
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

Review 3.  Disrupting insulin-like growth factor signaling as a potential cancer therapy.

Authors:  Deepali Sachdev; Douglas Yee
Journal:  Mol Cancer Ther       Date:  2007-01       Impact factor: 6.261

4.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

5.  Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo.

Authors:  Xueping Zhang; Marcia V Fournier; Joy L Ware; Mina J Bissell; Adly Yacoub; Zendra E Zehner
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

6.  Beta1-integrins are critical for cerebellar granule cell precursor proliferation.

Authors:  Sandra Blaess; Diana Graus-Porta; Richard Belvindrah; Randor Radakovits; Sebastian Pons; Amanda Littlewood-Evans; Mathias Senften; Huailian Guo; Yuqing Li; Jeffrey H Miner; Louis F Reichardt; Ulrich Müller
Journal:  J Neurosci       Date:  2004-03-31       Impact factor: 6.167

7.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Authors:  Catherine C Park; Hui J Zhang; Evelyn S Yao; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma.

Authors:  M Fornaro; G Tallini; D Q Zheng; W M Flanagan; M Manzotti; L R Languino
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 9.  GLI transcription factors: mediators of oncogenic Hedgehog signalling.

Authors:  Maria Kasper; Gerhard Regl; Anna-Maria Frischauf; Fritz Aberger
Journal:  Eur J Cancer       Date:  2006-01-10       Impact factor: 9.162

10.  Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins.

Authors:  Hira Lal Goel; Mara Fornaro; Loredana Moro; Natalia Teider; Johng S Rhim; Michael King; Lucia R Languino
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

View more
  23 in total

Review 1.  Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

2.  PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

Authors:  Leslie Ann Caromile; Kristina Dortche; M Mamunur Rahman; Christina L Grant; Christopher Stoddard; Fernando A Ferrer; Linda H Shapiro
Journal:  Sci Signal       Date:  2017-03-14       Impact factor: 8.192

3.  Ihog proteins contribute to integrin-mediated focal adhesions.

Authors:  Yun Qi; Han Liu; Kang Zhang; Yihui Wu; Chenghao Shen; Xinhua Lin
Journal:  Sci China Life Sci       Date:  2022-09-08       Impact factor: 10.372

4.  β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.

Authors:  Hira Lal Goel; Aejaz Sayeed; Michael Breen; Matthew J Zarif; David S Garlick; Irwin Leav; Roger J Davis; Thomas J Fitzgerald; Andrea Morrione; Chung-Cheng Hsieh; Qin Liu; Adam P Dicker; Dario C Altieri; Lucia R Languino
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

5.  β4 Integrin signaling induces expansion of prostate tumor progenitors.

Authors:  Toshiaki Yoshioka; Javier Otero; Yu Chen; Young-Mi Kim; Jason A Koutcher; Jaya Satagopan; Victor Reuter; Brett Carver; Elisa de Stanchina; Katsuhiko Enomoto; Norman M Greenberg; Peter T Scardino; Howard I Scher; Charles L Sawyers; Filippo G Giancotti
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

6.  β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy.

Authors:  Grant A Howe; Christina L Addison
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

7.  β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model.

Authors:  Kim Moran-Jones; Anita Ledger; Matthew J Naylor
Journal:  Sci Rep       Date:  2012-07-24       Impact factor: 4.379

8.  Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.

Authors:  I Tsaur; J Makarević; E Juengel; M Gasser; A-M Waaga-Gasser; M Kurosch; M Reiter; S Wedel; G Bartsch; A Haferkamp; C Wiesner; R A Blaheta
Journal:  Br J Cancer       Date:  2012-07-10       Impact factor: 7.640

9.  Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.

Authors:  Steffen Wedel; Lukasz Hudak; Jens-Michael Seibel; Jasmina Makarević; Eva Juengel; Igor Tsaur; Ana Waaga-Gasser; Axel Haferkamp; Roman A Blaheta
Journal:  BMC Cancer       Date:  2011-08-25       Impact factor: 4.430

10.  Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation.

Authors:  Samantha M Zunich; Maria Valdovinos; Taneka Douglas; David Walterhouse; Philip Iannaccone; Marilyn L G Lamm
Journal:  Mol Cancer       Date:  2012-07-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.